For example, high expression of ATG5 suggested a superior prognosis in breast cancer, colorectal cancer, and early-stage melanoma [40–42], but indicated a poor outcome in oral squamous cell carcinoma [43]. This evidence concerns the gene ATG5 and breast cancer.